Investors/Media

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet need. Learn more about our clinical pipeline here.

Corporate Presentation

Stock Information

Change

High

Minimum 15 minutes delayed. Source: LSEG

Events and Presentations

September 15, 2026 at 2:00 PM EDT
H.C. Wainwright 28th Annual Global Investment Conference Sign up
June 4, 2026 at 11:05 AM EDT
Jefferies Global Healthcare Conference in New York Sign up
May 21, 2026 at 1:00 PM EDT
2026 Annual Meeting of Stockholders Sign up